- 全部删除
- 您的购物车当前为空
Tyrosine kinase-IN-1是一种多靶点酪氨酸激酶抑制剂,能够抑制KDR (IC50:4 nM),Flt-1 (IC50:20 nM),FGFR1 (IC50:4 nM) 和 PDGFRα (IC50:2 nM)。
为众多的药物研发团队赋能,
让新药发现更简单!
Tyrosine kinase-IN-1是一种多靶点酪氨酸激酶抑制剂,能够抑制KDR (IC50:4 nM),Flt-1 (IC50:20 nM),FGFR1 (IC50:4 nM) 和 PDGFRα (IC50:2 nM)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 372 | In stock | |
5 mg | ¥ 579 | In stock | |
10 mg | ¥ 993 | In stock | |
25 mg | ¥ 1,990 | In stock | |
50 mg | ¥ 2,970 | 5日内发货 | |
100 mg | ¥ 4,290 | 5日内发货 | |
1 mL x 10 mM (in DMSO) | ¥ 637 | In stock |
XL 999 相关产品
产品描述 | Tyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor(KDR, Flt-1, FGFR1 and PDGFRα with IC50s of 4nM, 20nM, 4nM, 2 nM ,respectively) |
靶点活性 | FGFR1:2 nM , PDGFRα:4 nM , FLK1:4 nM , KDR:20 nM |
体内活性 | Tyrosine kinase-IN-1在大鼠中展示了合理的药代动力学特性(AUC(0–∞)=1.9,t1/2=4.6小时),且具有较好的口服生物利用度(F=63%)。 |
分子量 | 445.53 |
分子式 | C26H28FN5O |
CAS No. | 705946-27-6 |
Smiles | CCN1CCC(CC1)Nc1ccc2NC(=O)\C(=C(/c3ncc(C)[nH]3)c3cccc(F)c3)c2c1 |
密度 | 1.280 g/cm3 (Predicted) |
存储 | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 62.5 mg/mL (140.28 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容